128 related articles for article (PubMed ID: 21295244)
1. Editorial comment.
Jacobs BL; Skolarus TA; Hollenbeck BK
Urology; 2011 Feb; 77(2):279. PubMed ID: 21295244
[No Abstract] [Full Text] [Related]
2. Overuse of imaging for staging low risk prostate cancer.
Choi WW; Williams SB; Gu X; Lipsitz SR; Nguyen PL; Hu JC
J Urol; 2011 May; 185(5):1645-9. PubMed ID: 21419444
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment.
Cooperberg MR
Urology; 2011 Jun; 77(6):1336-7. PubMed ID: 21624594
[No Abstract] [Full Text] [Related]
4. Clinical Decision Support Systems and Advanced Diagnostic Imaging.
Cook TW; Cavalini LT
JAMA; 2015 Oct; 314(14):1518-9. PubMed ID: 26462003
[No Abstract] [Full Text] [Related]
5. Clinical Decision Support Systems and Advanced Diagnostic Imaging--Reply.
Hussey PS; Kahn KL
JAMA; 2015 Oct; 314(14):1519. PubMed ID: 26462006
[No Abstract] [Full Text] [Related]
6. Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer".
Ablin RJ; Sartor O; Bennett CL
Arch Intern Med; 2010 Aug; 170(15):1397-9. PubMed ID: 20696969
[No Abstract] [Full Text] [Related]
7. Reducing unnecessary follow-up imaging for adnexal lesions.
Chaudhary V; Bano S
J Am Coll Radiol; 2014 Jul; 11(7):745. PubMed ID: 24993539
[No Abstract] [Full Text] [Related]
8. Appropriateness of advanced diagnostic imaging ordering before and after implementation of clinical decision support systems.
Hussey PS; Timbie JW; Burgette LF; Wenger NS; Nyweide DJ; Kahn KL
JAMA; 2015 Jun; 313(21):2181-2. PubMed ID: 26034960
[No Abstract] [Full Text] [Related]
9. The chosen.
Hillman BJ
J Am Coll Radiol; 2012 May; 9(5):303-4. PubMed ID: 22554623
[No Abstract] [Full Text] [Related]
10. Excessive imaging for breast cancer in Ontario.
Burki TK
Lancet Oncol; 2015 Aug; 16(8):e381. PubMed ID: 26143689
[No Abstract] [Full Text] [Related]
11. Do Wise Choices Translate Into Cost Savings and Improved Outcomes?
Blayney DW
J Oncol Pract; 2015 Jul; 11(4):344-5. PubMed ID: 26060226
[No Abstract] [Full Text] [Related]
12. Choosing Wisely and Imaging 3.0 Professional Development: Radiology Resident Consultant Service.
Trakhtenbroit M; Abdollahian D; Horton KM; Johnson PT
J Am Coll Radiol; 2016 Jun; 13(6):730-2. PubMed ID: 27106487
[No Abstract] [Full Text] [Related]
13. [Value of imaging procedures in staging prostate cancer. Is CT out?].
Engelmann U
Urologe A; 1992 Jul; 31(4):195. PubMed ID: 1514195
[No Abstract] [Full Text] [Related]
14. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.
Cooperberg MR; Lubeck DP; Grossfeld GD; Mehta SS; Carroll PR
J Urol; 2002 Aug; 168(2):491-5. PubMed ID: 12131295
[TBL] [Abstract][Full Text] [Related]
15. Are staging investigations being overused in patients with low and intermediate risk prostate cancer?
Kim L; Min M; Roos D; Nguyen L; Yeoh E
J Med Imaging Radiat Oncol; 2015 Feb; 59(1):77-81. PubMed ID: 25186469
[TBL] [Abstract][Full Text] [Related]
16. Editorial comment.
Prasad SM; Sartor O; Bennett CL
Urology; 2014 Apr; 83(4):786-7. PubMed ID: 24680449
[No Abstract] [Full Text] [Related]
17. Active surveillance preferred for low-risk prostate cancer.
Bagcchi S
Lancet Oncol; 2015 Aug; 16(8):e384. PubMed ID: 26190749
[No Abstract] [Full Text] [Related]
18. Regarding "Emergency Physician Perceptions of Medically Unnecessary Advanced Diagnostic Imaging".
Frei S
Acad Emerg Med; 2015 Oct; 22(10):1231. PubMed ID: 26375395
[No Abstract] [Full Text] [Related]
19. Editorial comment.
Magi-Galluzzi C
J Urol; 2010 Jan; 183(1):157. PubMed ID: 19914653
[No Abstract] [Full Text] [Related]
20. Stage migration and grade inflation in prostate cancer: Will Rogers meets Garrison Keillor.
Thompson IM; Canby-Hagino E; Lucia MS
J Natl Cancer Inst; 2005 Sep; 97(17):1236-7. PubMed ID: 16145036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
